Impact of Positive Mental Vs. Physical Health Messaging on Motivation to Stop Smoking

January 7, 2025 updated by: Katherine Sawyer

What is the Effect of Presenting Evidence of the Mental Vs Physical Health Benefits of Quitting Smoking on Motivation to Stop Smoking? an Online Randomised Controlled Experiment

This study tested whether positive messages on tobacco packaging about the mental health benefits of quitting smoking could help motivate people to stop smoking. It compared three types of labels: ones focusing on mental health benefits, ones focusing on physical health benefits, and blank labels.

The experiment involved 631 people who smoke who were randomly shown one of these label types on an online survey platform. Participants' motivation to quit smoking was measured before and after viewing the labels.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

631

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Self-reported weekly tobacco smokers
  2. Aged at least 18 years
  3. Could read English

Exclusion Criteria:

Did not smoke tobacco at least weekly

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Positive mental health labels

Participants viewed four messages, formatted as tobacco packaging labels, communicating the benefits of smoking cessation for mental health. The messages were:

  • "Quitting smoking improves your mental health"
  • "Quitting smoking reduces feelings of depression"
  • "Quitting smoking reduces feelings of anxiety"
  • "Quitting smoking can improve your mood"
The intervention was messages of the benefits of smoking cessation formatted as tobacco packaging labels with three conditions. Participants viewed the messages online. There were four messages in each condition. The intervention was informed by relevant patient and public groups.
Active Comparator: Positive physical health labels

Participants viewed four messages, formatted as tobacco packaging labels, communicating the benefits of smoking cessation for physical health. The messages were:

  • "Quitting smoking improves your health"
  • "Quitting smoking reduces risk your risk of having a heart attack"
  • "Quitting smoking reduces shortness of breath and coughing"
  • "Quitting smoking can improve your oral health"
The intervention was messages of the benefits of smoking cessation formatted as tobacco packaging labels with three conditions. Participants viewed the messages online. There were four messages in each condition. The intervention was informed by relevant patient and public groups.
Placebo Comparator: Blank labels

Participants viewed four blank messages, formatted as tobacco packaging labels. The messages were:

  • Blank template
  • Template with "Example"
  • Template with "Template"
  • Template with "Image, Text"
The intervention was messages of the benefits of smoking cessation formatted as tobacco packaging labels with three conditions. Participants viewed the messages online. There were four messages in each condition. The intervention was informed by relevant patient and public groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motivation to stop smoking
Time Frame: At baseline and follow up immediately after viewing the labels
Motivation to stop smoking was measured using the Motivation to Stop Scale (MTSS). The MTSS asks participants "Which of the following best describes you?" with the following ordinal scale: 1) "I don't want to stop smoking"; 2) "I think I should stop smoking but don't really want to"; 3) "I want to stop smoking but haven't thought about when"; 4) "I REALLY want to stop smoking but I don't know when I will"; 5) "I want to stop smoking and hope to soon"; 6) "I REALLY want to stop smoking and intend to in the next 3 months"; 7) "I REALLY want to stop smoking and intend to in the next month".
At baseline and follow up immediately after viewing the labels

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intention to Quit
Time Frame: Measured at baseline and follow up immediately after viewing the labels
Participants were asked their intention to quit smoking "Are you planning to quit smoking within the next month?" using a 10-point visual analogue scale, where 1 indicates low intention to quit and 10 indicates higher intention to quit smoking
Measured at baseline and follow up immediately after viewing the labels
Quitting Self-Efficacy
Time Frame: Measured at baseline and follow up immediately after viewing the labels
To measure participants' self-efficacy to quit smoking, participants responded to the questions "Overall, how confident are you that you can stop smoking within the next month?" on a 5-point scale 1 ('not at all') to 5 ('completely confident') and "For me cutting down on the number of cigarettes that I smoke in the next month would be…." On a scale off 1 ('very difficult') to 5 ('very easy'). The mean score across the two items was calculated, with a higher score indicating higher self-efficacy
Measured at baseline and follow up immediately after viewing the labels
Smoking Beliefs
Time Frame: Measured at baseline and follow up immediately after viewing the labels
Participants rated their agreement to the statements "smoking helps people relax", "smoking helps to reduce stress", "smoking helps to keep weight down" "smoking increases social comfort" "those who smoke are more popular" and "second hand smoke is not harmful" using a 5-point scale from 1 ('not at all') to 5 ('a lot'). The mean score across the five items was calculated, with a higher score indicating more favourable beliefs towards smoking
Measured at baseline and follow up immediately after viewing the labels
Attention
Time Frame: Measured at follow up immediately after viewing the labels
Participants rated two statements 'these labels are worth remembering' and 'these labels grabbed my attention' on a 5-point scale from 1 ('not at all') to 5 ('a lot'), mean score across the two items was calculated, with a higher score indicating greater attention
Measured at follow up immediately after viewing the labels
Affective Reactions
Time Frame: Measured at follow up immediately after viewing the labels
To measure affective reactions to the health labels we used the Self-Assessment Manakin (SAM, (Bradley & Lang, 1994)). Participants rated their affective reactions: valence, arousal, and dominance on a 9-point visual analogue scale. Scales for valence range from 1 'unpleasant' to 9 'pleasant', arousal ranged from 1 'calm' to 9 'excited', and dominance ranged from 1 'controlled' to 9 'in control' with 5 as neutral for all items
Measured at follow up immediately after viewing the labels
Believability
Time Frame: Measured at follow up immediately after viewing the labels
Perceptions of believability of the health label were measured using the question "How believable are these health labels?", participants rated this on a 5-point scale from 1 ('not at all') to 5 ('a lot')
Measured at follow up immediately after viewing the labels

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gemma Taylor, PhD, University of Bath

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Actual)

February 28, 2023

Study Completion (Actual)

February 28, 2023

Study Registration Dates

First Submitted

December 19, 2024

First Submitted That Met QC Criteria

January 6, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 7, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The datasets generated and/or analysed during the current study are available in the University of Bath repository.

IPD Sharing Time Frame

Data will be available on publication and indefinitely

IPD Sharing Access Criteria

Scripts are available at https://osf.io/v5deq/?view_only=d5dd1f5903a0480d94402c7c6528c6a4

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Study Data/Documents

  1. Individual Participant Data Set
    Information comments: The datasets generated and/or analysed during the current study are available in the University of Bath repository.
  2. Analytic Code
    Information comments: Scripts are available on Open Science Framework

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking, Tobacco

Clinical Trials on Messages on tobacco packaging labels

Subscribe